Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Karthaus

Showing results (11-20 of 100) with videos related to

Pageof 10
Sort By:
Wiener Medizinische Wochenschrift (1946)|January 16, 2002
[Changes in the epidemiology of infections in patients with febrile neutropenia]M Karthaus, J Carratala
Current Opinion in Oncology|July 1, 1996
Clinical use of hematopoietic growth factorsA Ganser, M Karthaus
Leukemia & Lymphoma|May 7, 1998
Clinical use of hematopoietic growth factors in the myelodysplastic syndromesA Ganser, M Karthaus
Therapeutische Umschau. Revue Therapeutique|November 1, 1996
[Current status of the clinical application of hematopoietic growth factors in oncology]M Karthaus, A Ganser
Wiener Medizinische Wochenschrift (1946)|January 16, 2002
[Supportive care in hematologic oncology]M Karthaus, J Meran
Antibiotics and Chemotherapy|June 30, 2000
Treatment of systemic fungal infections in patients with hematologic malignanciesA Böhme, M Karthaus
Journal of Chemotherapy (Florence, Italy)|July 19, 2003
Ceftriaxone in febrile neutropeniaM Karthaus, O A Cornely
European Journal of Haematology|July 8, 1998
Detection of chronic systemic candida infection in leukaemia patients with febrile neutropenia: value of computer-assisted serial ultrasound documentationM Karthaus, G Huebner, C Elser, et al.
Wiener Medizinische Wochenschrift (1946)|January 16, 2002
[Thromboembolism complications in tumor diseases: pathophysiology, risk factors and preventive approaches]T Südhoff, W Schmiegel, M Karthaus
Chemotherapy|February 15, 2000
Evaluation of neutropenic fever: value of serum and plasma parameters in clinical practiceT Südhoff, A Giagounidis, M Karthaus
Pageof 10

Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Wiener Medizinische Wochenschrift (1946)|January 16, 2002
[Changes in the epidemiology of infections in patients with febrile neutropenia]M Karthaus, J Carratala
Current Opinion in Oncology|July 1, 1996
Clinical use of hematopoietic growth factorsA Ganser, M Karthaus
Leukemia & Lymphoma|May 7, 1998
Clinical use of hematopoietic growth factors in the myelodysplastic syndromesA Ganser, M Karthaus
Therapeutische Umschau. Revue Therapeutique|November 1, 1996
[Current status of the clinical application of hematopoietic growth factors in oncology]M Karthaus, A Ganser
Wiener Medizinische Wochenschrift (1946)|January 16, 2002
[Supportive care in hematologic oncology]M Karthaus, J Meran
Antibiotics and Chemotherapy|June 30, 2000
Treatment of systemic fungal infections in patients with hematologic malignanciesA Böhme, M Karthaus
Journal of Chemotherapy (Florence, Italy)|July 19, 2003
Ceftriaxone in febrile neutropeniaM Karthaus, O A Cornely
European Journal of Haematology|July 8, 1998
Detection of chronic systemic candida infection in leukaemia patients with febrile neutropenia: value of computer-assisted serial ultrasound documentationM Karthaus, G Huebner, C Elser, et al.
Wiener Medizinische Wochenschrift (1946)|January 16, 2002
[Thromboembolism complications in tumor diseases: pathophysiology, risk factors and preventive approaches]T Südhoff, W Schmiegel, M Karthaus
Chemotherapy|February 15, 2000
Evaluation of neutropenic fever: value of serum and plasma parameters in clinical practiceT Südhoff, A Giagounidis, M Karthaus
Pageof 10